Patients to skip the lab, get immediate results with new blood test technology
Share

IMAGE: First mobile version of the Enzyme Linked Immunosorbent Assay (ELISA), the gold standard in biochemical analysis. view more 

view more 

TAMPA, Fla. (March 26, 2018)- The often costly, time consuming process of obtaining bloodwork and urinalysis could soon get a major overhaul. Researchers at the University of South Florida in Tampa have created a mobile version of the “Enzyme Linked Immunosorbent Assay” (ELISA), the gold standard technique used to detect the presence of an antibody or antigen. Instead of sending patients to a laboratory, new cellphone-based technology allows for the very same test to be conducted in the doctor’s office, clinic or even in a remote area.

“ELISA is an important technology for biochemical analysis of proteins and hormones and is critical for the diagnosis of many diseases, such as HIV and Lyme Disease,” said corresponding author Anna Pyayt, PhD, assistant professor at the University of South Florida College of Engineering. “But the machines required for the incubation and reading are expensive and bulky. The MELISA allows patients to undergo testing and obtain results at point-of-care.”

The Mobile Enzyme Linked Immunosorbent Assay (MELISA) is detailed in an article just published in Biosensors and Bioelectronics. The device accurately measures progesterone levels, a

read more...


Article originally posted at
www.eurekalert.org

Click here for the full story


CategoryAggregator News

© 2017 - LIFE EXTENSION ADVOCACY FOUNDATION
Privacy Policy / Terms Of Use

Powered by MMD